Study Suggests Cell-Free DNA Approach Can Outperform Standard Screens for Fetal Aneuploidy | GenomeWeb

NEW YORK (GenomeWeb News) – A new multi-center study performed in the US suggests fetal aneuploidy screening based on cell-free DNA sequencing from pregnant women's blood finds fewer false-positive cases than standard serum screening methods in a general population of pregnant women.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.